More patients in the Xeloda and Tykerb group had dose reductions, diarrhea, vomiting and a condition called hand-foot syndrome which is redness, swelling and pain on the hands or feet.
The treatments left him weak and fatigued, with pain and numbness in his feet that threw off his balance and left him unable to walk steadily and unable to stop himself from falling if he tripped.